Be. Maryanoff et al., STRUCTURE-ACTIVITY STUDIES ON ANTICONVULSANT SUGAR SULFAMATES RELATEDTO TOPIRAMATE - ENHANCED POTENCY WITH CYCLIC SULFATE DERIVATIVES, Journal of medicinal chemistry, 41(8), 1998, pp. 1315-1343
We have explored the structure-activity relationship (SAR) surrounding
the clinically efficacious antiepileptic drug topiramate (1), a uniqu
e sugar sulfamate anticonvulsant that was discovered in our laboratori
es. Systematic structural modification of the parent compound was dire
cted to identifying potent anticonvulsants with a long duration of act
ion and a favorable neurotoxicity index. In this context, we have prob
ed the pharmacological importance of several molecular features: (1) t
he sulfamate group (6-8, 22-25, 27, 84), (2) the linker between the su
lfamate group and the pyran ring (9, 10, 21a,b), (3) the substituents
on the 2,3- (58-60, 85, 86) and 4,5-fused (30-38, 43, 45-47, 52, 53) 1
,3-dioxolane rings, (4) the constitution of the 4,5-fused 1,3-dioxolan
e ring (2, 54, 55, 63-68, 76, 77, 80, 83a-r, 84-87, 90a, 91a, 93a), (5
) the ring oxygen atoms (95, 96, 100-102, 104, 105), and (6) the absol
ute stereochemistry (106 and 107). We established the C1 configuration
as R for the predominant alcohol diastereomer from the highly selecti
ve addition of methylmagnesium bromide to aldehyde 15 (16:1 ratio) by
single-crystal x-ray analysis of the major diastereomer of sulfamate 2
1a. Details for the stereoselective syntheses of the hydrindane carboc
yclic analogues 95, 96, 100, and 104 are presented. We also report the
synthesis of cyclic imidosulfites 90a and 93a, and imidosulfate 91a,
which are rare examples in the class of such five-membered-ring sulfur
species. Imidosulfite 93a required the preparation and use of the nov
el sulfur dichloride reagent, BocN=SCl2. Our SAR investigation led to
the impressive 4,5-cyclic sulfate analogue 2 (RWJ-37947), which exhibi
ts potent anticonvulsant activity in the maximal electroshock seizure
(MES) test (ca. 8 times greater than 1 in mice at 4 h, ED50 = 6.3 mg/k
g; ca. 15 times greater than 1 in rats at 8 h, ED50 = 1.0 mg/kg) with
a long duration of action (>24 h in mice and rats, po) and very low ne
urotoxicity (TD50 value of >1000 mg/kg at 2 h, p0 in mice). Cyclic sul
fate 2, like topiramate and phenytoin, did not interfere with seizures
induced by pentylenetetrazole, bicucculine, picrotoxin, and strychnin
e; also, 2 was not active in diverse in vitro receptor binding and upt
ake assays. However, 2 turned out to be a potent inhibitor of carbonic
anhydrase from different rat tissue sources (e.g., IC50 of 84 nM for
the blood enzyme and 21 nM for the brain enzyme). An examination of se
veral analogues of 2 (83a-r, 85-87, 90a, 91a, 93a) indicated that pote
nt anticonvulsant activity is associated with relatively small alkyl s
ubstituents on nitrogen (Me/H, 83a; Me/Me, 83m; Et/H, 83b; allyl/H, 83
e; c-Pr/H, 83j; c-Bu/H, 83k) and with limited changes in the cyclic su
lfate group, such as 4,5-cyclic sulfite 87a/b. The potent anticonvulsa
nts 83a and 83j had greatly diminished carbonic anhydrase inhibitory a
ctivity; thus, inhibition of this enzyme may not be a significant fact
or in the anticonvulsant activity. The alpha-L-sorbopyranoses 67, 68,
and 80, which mainly possess a skew conformation (ref 29), were nearly
twice as potent as topiramate (1). The L-fructose enantiomers of 1 (1
06) and 2 (107), synthesized from L-sorbose, were found to have modera
te anticonvulsant activity, with eudysmic ratios (MES ED50 in mice at
4 h, p0) of 1:106 = 1.5 and 2:107 = 3.5. The log P values for 1 and 2
were determined experimentally to be 0.53 and 0.42, respectively, whic
h are less than the optimal 2.0 for CNS active agents. However, analog
ues with more favorable calculated log P (clogP) values, in conjunctio
n with just minor steric perturbation according to the developed SAR p
rofile, such as 47 (clog P = 2.09), 83m (1.93), and 86 (1.50), did not
display improved potency: 47 is less potent than 1, 83m is equipotent
with 2, and 86 is less potent than 2. Although the measured log P val
ue for diethyl analogue 31 is 1.52, this did not translate into enhanc
ed potency relative to 1. The 400-MHz H-1 NMR studies of 1 and 2 indic
ated that the skew (3)So conformer predominates at ambient temperature
in nonaqueous and aqueous media; 95 strongly populates a skew (3)So c
onformer in benzene and (as reported in ref 29) 67 mainly adopts this
skew conformation in various solvents. X-ray crystal structures for 1,
2, and 95 (as well as 67) depict the skew (3)So conformer in the soli
d state. Solution IR studies with 1, 2, and 83b showed an absence of i
ntramolecular hydrogen bonding, in contrast to what has been observed
for alcohol 4 (ref 73).